How I Treat How I treat older patients with ALL
نویسنده
چکیده
3104. 60. Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensiveconsolidation for adults with acute lymphoblasticleukemia: cancer and leukemia group B study8811. Blood. 1995;85(8):2025-2037. 61. van Schie RM, Brüggemann RJ, HoogerbruggePM, te Loo DM. Effect of azole antifungal therapyon vincristine toxicity in childhood acutelymphoblastic leukaemia. J AntimicrobChemother. 2011;66(8):1853-1856. 62. Sekeres MA, Elson P, Kalaycio ME, et al. Timefrom diagnosis to treatment initiation predictssurvival in younger, but not older, acute myeloidleukemia patients. Blood. 2009;113(1):28-36. 63. Bertoli S, Berard E, Huguet F, et al. Time fromdiagnosis to intensive chemotherapy initiation does not adversely impact the outcome ofpatients with acute myeloid leukemia. Blood. 2013. Prepublished on 2013/02/01 as DOI10.1182/blood-2012-09-454553. 64. Delannoy A, Cazin B, Thomas X, et al; LALAGroup, France and Belgium. Treatment of acutelymphoblastic leukemia in the elderly: an1374 GÖKBUGETBLOOD, 22 AUGUST 2013 x VOLUME 122, NUMBER 8For personal use only.on July 14, 2017.by guestwww.bloodjournal.orgFrom
منابع مشابه
“How should we treat older patients with Metastatic Colorectal Cancer, A Review”
Nearly 50 % of newly diagnosed colorectal cancer, affect people over 70 years of age. Inclusion of older patients in clinical trials has been extremely rare. As a result, there is debate on how to manage these patients because it is still unclear how to balance the therapeutic advantages and toxicities. For patients who do not have comorbid conditions, with performance status (P.S.) 0–1, treatm...
متن کاملHow I treat How I treat elderly patients with myeloma
The clinical approach to older patients with myeloma has to be modified to take into account comorbidities and the likelihood of higher treatment-related toxicity. Individualization of management and adequate supportive therapy are important to obtain the best response while minimizing adverse effects. Corticosteroids, novel agents, conventional cytotoxic agents, and high-dose chemotherapy with...
متن کاملHow I treat How I treat acute myeloid leukemia
More than one quarter of a million adults throughout the world are diagnosed annually with acute myeloid leukemia (AML). Despite considerable progress during the past 3 decades in the therapy of AML, two-thirds of young adults and 90% of older adults still die of their disease. The reported median age has increased over the past few decades, mostly because of a greater willingness of physicians...
متن کاملHow to Treat the Complex Unstable Intertrochanteric Fractures in Elderly Patients? DHS or Arthroplasty
Background: Due to difficulty in obtaining anatomical reduction, management of the unstable intertrochanteric fractures in elderly osteoporotic patients is challenging. The purpose of this study is to compare the results of hip arthroplasty (total, hemi, or bipolar) with DHS in the elderly patients with unstable intertrochanteric fractures. Methods: We prospectively studied and followed-up ...
متن کاملI-38: New and Old Technologies in the Modern IVF Clinic
Background PGD has been around in various forms for over a quarter of a century now. During this time it has evolved from simple FISH and direct PCR mutation analysis to whole chromosome profiling using microarrays or next generation sequencing and improved monogene testing using STR linkage or now, recombination mapping. Modern PGD can now deliver highly accurate and reproducible results capab...
متن کاملHow I treat How I treat Gaucher disease
This review presents a cohesive approach to treating patients with Gaucher disease. The spectrum of the clinical presentation of the disease is broad, yet heretofore there was only one diseasespecific treatment. In the past 2 years, a global shortage of this product has resulted in reassessment of the “one enzyme–one disease–one therapy” mantra. It has also showcased the multiple levels that en...
متن کامل